Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Dalteparin × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 7 Tumor-Agnostic 1 Other 1

Conditions

Venous Thromboembolism 1 Obesity 1 Neoplasms 1

Interventions

naloxegol 3 Surveys and Questionnaires 3 Resistance Training 3 Nutrition Assessment 3 Exercise 3 alvimopan 2 Therapeutics 2 Psychiatric Rehabilitation 2 Oxygen 2 Nutritional Status 2 Mouthwashes 2 Morphine 2 Interviews as Topic 2 Counseling 2 semaglutide 1 naldemedine 1 methylnaltrexone 1 kang-lai-te 1 hydrated silica gel-based toothpaste 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 calcium phosphate 1 auricularum 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Weights and Measures 1 Walking 1 Urine Specimen Collection 1 Toothbrushing 1 Standard of Care 1 Spermine Synthase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297359 2024-01-23

WAVe

Ottawa Hospital Research Institute

Phase 2 Terminated

Classical hematologyOther

Neoplasms, Obesity, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡